Pilot study on tolerability of specific immunotherapy with injective allergoid adsorbed on calcium phosphate in patients with respiratory allergy to house dust mite.
Phase of Trial: Phase II
Latest Information Update: 18 Aug 2011
At a glance
- Drugs House dust mite allergy immunotherapy (Primary)
- Indications Allergic asthma; Allergic rhinoconjunctivitis
- Focus Adverse reactions
- 18 Aug 2011 New trial record